Literature DB >> 15482295

The role of oxidants and antioxidants in generalized vitiligo at tissue level.

M Yildirim1, V Baysal, H S Inaloz, M Can.   

Abstract

BACKGROUND: The role of oxidative stress has not been fully understood in the aetiopathogenesis of vitiligo in different studies. AIM: We aimed to investigate the role of the oxidative stress in the pathogenesis of vitiligo.
METHODS: In this study, we examined levels of superoxide dismutase, glutathione peroxidase, malondialdehyde and nitric oxide in tissue of 25 patients with generalized vitiligo and 25 healthy controls.
RESULTS: Our results revealed that levels of superoxide dismutase, glutathione peroxidase and malondialdehyde in tissue were significantly increased in patients with generalized vitiligo (P < 0.05). However, there was no statistically significantly difference between two groups at tissue level of nitric oxide (P > 0.05).
CONCLUSION: Our results demonstrate the presence of an imbalance in the oxidant-antioxidant system in vitiligo at tissue level and provide further support for a free radical-mediated damage as an initial pathogenic event in melanocyte degeneration in vitiligo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482295     DOI: 10.1111/j.1468-3083.2004.01080.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  20 in total

1.  Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo.

Authors:  Yasser E Elassiuty; Jared Klarquist; Jodi Speiser; Randa M Yousef; Abdelaziz A El Refaee; Nahla S Hunter; Olfat G Shaker; Mohan Gundeti; Ludmila Nieuweboer-Krobotova; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2011-03-22       Impact factor: 3.960

Review 2.  Highlights in pathogenesis of vitiligo.

Authors:  Ghada F Mohammed; Amal Ha Gomaa; Mohammed Saleh Al-Dhubaibi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

3.  The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.

Authors:  Omotayo A Arowojolu; Seth J Orlow; Nada Elbuluk; Prashiela Manga
Journal:  Exp Dermatol       Date:  2017-07       Impact factor: 3.960

4.  Erythrocyte malondialdehyde and glutathione levels in vitiligo patients.

Authors:  Jung Won Shin; Kyung Mi Nam; Hye Ryung Choi; Sun Young Huh; Shin Woo Kim; Sang Woong Youn; Chang Hun Huh; Kyoung Chan Park
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

5.  Reduced serum paraoxonase-1 levels in vitiligo: further evidence of oxidative stress.

Authors:  Yavuz Yesilova; Enver Turan; Derya Ucmak; Sahabettin Selek; İbrahim Halil Yavuz; Osman Tanrıkulu
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

6.  Apigenin protects human melanocytes against oxidative damage by activation of the Nrf2 pathway.

Authors:  Baoxiang Zhang; Jing Wang; Guodong Zhao; Mao Lin; Yong Lang; Diancai Zhang; Dianqin Feng; Caixia Tu
Journal:  Cell Stress Chaperones       Date:  2020-01-18       Impact factor: 3.667

7.  Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.

Authors:  Siavash Toosi; Seth J Orlow; Prashiela Manga
Journal:  J Invest Dermatol       Date:  2012-06-14       Impact factor: 8.551

8.  Uric Acid: a new antioxidant in patients with pemphigus vulgaris.

Authors:  Maryam Yousefi; Hoda Rahimi; Behrooz Barikbin; Parviz Toossi; Sara Lotfi; Mehdi Hedayati; Shima Younespour
Journal:  Indian J Dermatol       Date:  2011-05       Impact factor: 1.494

9.  Oxidative stress in experimental vitiligo C57BL/6 mice.

Authors:  Akrem Jalel; Mrabet Yassine; Mohamed Hédi Hamdaoui
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

10.  Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.

Authors:  Miao-ni Zhou; Zhi-qing Zhang; Ji-long Wu; Fu-quan Lin; Li-fang Fu; Sui-qan Wang; Cui-ping Guan; Hong-lin Wang; Aie Xu
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.